Clinical Trial Update: Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of a neoantigen-based personalized DNA vaccine for newly diagnosed unmethylated glioblastoma, with Washingt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Neoantigen-based Personalized DNA Vaccine

Snippet

Sponsor: Washington University School of Medicine | Conditions: Glioblastoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING